$PMCB 3 SEC Filings

Filed On	Filing
30 May 2024	Form 3: PharmaCyte Biotech, Inc., 10% owner · Q/C Technologies Inc
28 Nov 2023	Form 3: PharmaCyte Biotech, Inc., 10% owner · Femasys Inc
30 Dec 2022	Form 3: Walker Wayne Remell, Director No securities owned
16 Nov 2022	Form 3: Weinstein Robert, Director No securities owned
24 Aug 2022	Form 3: Allen Daniel, Director Holds 260,000 shares of Common Shares
23 Aug 2022	Form 3: Schechter Jonathan, Director Holds 50,000 shares of Common Stock
23 Aug 2022	Form 3: Stover Jack E, Director No securities owned
23 Aug 2022	Form 3: Silverman Joshua, Director Holds 50,000 shares of Common Stock
23 Aug 2022	Form 3: Farb Daniel Stuart, Director Holds 714,570 shares of Common Stock
11 Apr 2022	Form 3: Loehr Matthias, Director Holds 3,004 shares of Common Stock
03 Sep 2021	Form 3: Trujillo Carlos, Director Holds 8,800 shares of Common Stock
31 Aug 2021	Form 3: Waggoner Kenneth L., Director Holds 20,600 shares of Common Stock
31 Aug 2021	Form 3: Yuen Thomas C K, Director Holds 1,667 shares of Common Stock
31 Aug 2021	Form 3: Crabtree Gerald W, Director Holds 11,200 shares of Common Stock
20 Aug 2021	Form 3: Liquard Thomas, Director Holds 1,667 shares of Common Stock
20 Aug 2021	Form 3: Tong Raymond Cf, Director Holds 1,333 shares of Common Stock
20 Aug 2021	Form 3: Abecassis Michael M, Director Holds 1,667 shares of Common Stock
30 Mar 2009	Form 3: Schmieg Martin, Director Holds 425,328 shares of Common stock, par value $0.0001
30 Mar 2009	Form 3: Barnes Marylew, Director Holds 121,805 shares of Common stock, par value $0.0001

Comments